WallStreetZenWallStreetZen

NASDAQ: PRTC
Puretech Health PLC Stock

$28.00+0.00 (+0%)
Updated Jun 8, 2023
PRTC Price
$28.00
Fair Value Price
$44.30
Market Cap
$779.99M
52 Week Low
$18.15
52 Week High
$38.90
P/E
-15.56x
P/B
1.44x
P/S
58.78x
PEG
N/A
Dividend Yield
N/A
Revenue
$15.62M
Earnings
-$50.35M
Gross Margin
100%
Operating Margin
-679.17%
Profit Margin
-322.4%
Debt to Equity
0.29
Operating Cash Flow
-$179M
Beta
0.58
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

PRTC Overview

PureTech Health plc is developing medicines for intractable cancers, as well as inflammatory, fibrotic and immunological, lymphatic and gastrointestinal, and neurological and neuropsychological diseases in the U.S. KarXT (to treat schizophrenia and psychosis in Alzheimer's disease) is currently in-market. Under development are a regenerative biology platform for androgenetic alopecia, epithelial ageing, and other medical conditions, an immunomodulation platform to treat chronic and acute inflammatory disorders, and oral therapies based on defined consortia of bacteria is isolated from the human microbiome. Puretech Health was incorporated in 2015 and is headquartered in Boston, MA.

Zen Score

Industry Average (26)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how PRTC scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

PRTC ($28.00) is undervalued by 36.8% relative to our estimate of its Fair Value price of $44.30 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
PRTC ($28.00) is significantly undervalued by 36.8% relative to our estimate of its Fair Value price of $44.30 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
PRTC is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more PRTC due diligence checks available for Premium users.

Be the first to know about important PRTC news, forecast changes, insider trades & much more!

PRTC News

Valuation

PRTC fair value

Fair Value of PRTC stock based on Discounted Cash Flow (DCF)
Price
$28.00
Fair Value
$44.30
Undervalued by
36.80%
PRTC ($28.00) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
PRTC ($28.00) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
PRTC is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

PRTC price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-15.56x
Industry
11.75x
Market
52.58x

PRTC price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
1.44x
Industry
5.24x
PRTC is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

PRTC's financial health

Profit margin

Revenue
$0.0
Net Income
$0.0
Profit Margin
0%
PRTC's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
PRTC's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$702.6M
Liabilities
$155.1M
Debt to equity
0.29
PRTC's short-term assets ($386.19M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
PRTC's short-term assets ($386.19M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
PRTC's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
N/A
Investing
N/A
Financing
N/A
PRTC's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

PRTC vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
PRTC$779.99M0.00%-15.56x1.44x
IRON$781.48M+1.36%-0.92x3.36x
DYN$784.86M-5.74%-4.05x3.24x
LYEL$768.80M-5.52%-4.22x0.98x
AMAM$796.65M+5.34%N/A4.36x

Puretech Health Stock FAQ

What is Puretech Health's quote symbol?

(NASDAQ: PRTC) Puretech Health trades on the NASDAQ under the ticker symbol PRTC. Puretech Health stock quotes can also be displayed as NASDAQ: PRTC.

If you're new to stock investing, here's how to buy Puretech Health stock.

What is the 52 week high and low for Puretech Health (NASDAQ: PRTC)?

(NASDAQ: PRTC) Puretech Health's 52-week high was $38.90, and its 52-week low was $18.15. It is currently -28.02% from its 52-week high and 54.27% from its 52-week low.

How much is Puretech Health stock worth today?

(NASDAQ: PRTC) Puretech Health currently has 278,566,306 outstanding shares. With Puretech Health stock trading at $28.00 per share, the total value of Puretech Health stock (market capitalization) is $779.99M.

Puretech Health stock was originally listed at a price of $40.19 in Nov 18, 2020. If you had invested in Puretech Health stock at $40.19, your return over the last 2 years would have been -30.33%, for an annualized return of -16.53% (not including any dividends or dividend reinvestments).

How much is Puretech Health's stock price per share?

(NASDAQ: PRTC) Puretech Health stock price per share is $28.00 today (as of Jun 8, 2023).

What is Puretech Health's Market Cap?

(NASDAQ: PRTC) Puretech Health's market cap is $779.99M, as of Jun 9, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Puretech Health's market cap is calculated by multiplying PRTC's current stock price of $28.00 by PRTC's total outstanding shares of 278,566,306.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.